NCT06753825 is a clinical trial of Radiofrequency in Migraine Disease, sponsored by Damla Yürük.

Who is sponsoring NCT06753825?

NCT06753825 is sponsored by Damla Yürük.

What drugs are being tested in NCT06753825?

Interventions in NCT06753825: Radiofrequency, flunarizine.

What condition does NCT06753825 study?

NCT06753825 studies Migraine Disease.

Is NCT06753825 still recruiting?

NCT06753825 is currently active, enrolled. Last updated 13 January 2025.

Last reviewed 2025-01-13 · How we verify

NCT06753825

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Childhood Migraine Treatment Noninvasive Pulsed Radiofrequency vs Flunarizine

Active, enrolled Last updated 13 January 2025

What this trial tests

trial testing Radiofrequency in Migraine Disease in 60 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 October 2024

Primary endpoint
1 April 2025

30 May 2025

Quick facts

Lead sponsor	Damla Yürük
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	60
Start date	1 October 2024
Primary completion	1 April 2025
Estimated completion	30 May 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Radiofrequency — full drug profile →
flunarizine (FLUNARIZINE) — full drug profile →

Conditions studied

Migraine Disease — all drugs for Migraine Disease →

Sponsor

Damla Yürük

Who can join

Adults 7 to 17, any sex, with Migraine Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this observational study was to investigate the long-term effects of patients receiving interventional transcutaneous electrode-pulsed radiofrequency therapy versus calcium channel blockers for the treatment of childhood migraine pain. The main question to be answered was. Which of the long-term effects of interventional transcutaneous pulsed radiofrequency versus calcium channel blockers for the treatment of childhood migraine pain is more effective? Participants who have started both treatments will answer questions about their headaches in an online survey for 3 months as part of their regular medical care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Radiofrequency

Trials testing the same drug.

NCT07279142 — Efficacy and Safety of 7 Millimeters Vaginal Radiofrequency in Overactive Bladder · NA · not yet recruiting
NCT07213050 — Percutaneous Thermal Ablation (Radiofrequency and Microwave) in the Treatment of Anterior Abdominal Wall Masses: An Eval · NA · not yet recruiting
NCT07131943 — Radiofrequency vs. Ultrasound Therapy for Shoulder Joint in Stroke Patients: A Comparative Clinical Trial · NA · recruiting
NCT07097532 — Cutaneous Silent Period-Based Comparison of DRG-PRF and TFESI in Lumbar Radicular Pain · NA · active not recruiting
NCT06755099 — Female Sexual Dysfunction Assessment and Managment of Vaginismus · Phase 2, PHASE3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06753825 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Damla Yürük
Last refreshed: 13 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06753825.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing